Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Share-based Compensation: 2020-2021

Historic Share-based Compensation for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to $299,147.

  • Bright Minds Biosciences' Share-based Compensation was N/A to $299,147 in Q3 2021 from the same period last year, while for Sep 2021 it was $700,787, marking a year-over-year change of. This contributed to the annual value of $617,402 for FY2024, which is 27.75% down from last year.
  • Bright Minds Biosciences' Share-based Compensation amounted to $299,147 in Q3 2021, which was up 41.00% from $212,165 recorded in Q2 2021.
  • Bright Minds Biosciences' 5-year Share-based Compensation high stood at $299,147 for Q3 2021, and its period low was $90,522 during Q4 2020.
  • Over the past 2 years, Bright Minds Biosciences' median Share-based Compensation value was $155,559 (recorded in 2021), while the average stood at $175,197.